Cannabis Central: Pure-Play Pot Stock Portfolio Was Down 6.9% Last Week

While Friday was a very quiet day with the munKNEE.com Pure-Play Pot Stock Portfolio only going UP 0.3% on the day - with only 1 stock going UP more than 5% (Columbia +8.7%) and only 1 stock going DOWN more than 5%, namely, Aurora (-5.7%) - the portfolio performed poorly during the week, going DOWN 6.9%.

Below are the major winners and losers for the week ending September 4th:

Major Winners

5 of the stocks in the portfolio finished the week UP in price but none went up by at least 10%. Harvest Health did the best but was only UP 4.1%.

Major Losers

20 of the stocks in the portfolio finished the week DOWN in price with 10 going down by at least 9.5%, as follows:

1. Curaleaf (CURLF) -15.5%
2. Cresco (CRLBF) -15.1%
3. Aurora (ACB) -13.3%
4. cbdMD (YCBD) -12.2%
5. Medicine Man (SHWZ) -12.0%
6. Organigram (OGI) -10.2%
7. Tilray (TLRY) -10.2%
8. Trulieve (TCNNF) -9.9%
9. Green Thumb (GTBIF) -9.5%
10. Neptune (NEPT) -9.5%

The 25 munKNEE.com Pure-Play Pot Stock Portfolio has stocks doing business in 4 categories based on their primary area of focus in the cannabis industry and 3 of the 4 went DOWN last week. The categories are identified below with how they performed given the performance of the stocks in the portfolio that make up each category:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category has 21 portfolio participants that grow, process, and sell cannabis and hemp flower and related products and they went DOWN 7.1%, on average.
   • the 7 Canadian Licensed Producer (LPs) portfolio participants  (ACB; APHA; CGC; CRON; OGI; ROMJF and TLRY) went DOWN 6.9%, on average.
   • the 12 U.S. Multi-State Operator (MSOs) portfolio participants (ACRGF; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; HRVSF; JUSHF; PLNHF; SHWZ; TCNNF and TRSSF) went DOWN   7.0%, on average.
   • the 2 hemp seed-to-sale MSO portfolio participants (CWBHF and YCBD) went DOWN 9.6%, on average.
2. The Extraction Category has 2 portfolio participants (NEPT and VLNCF) focused on the extraction of cannabis compounds and their infusion into consumer products and they went DOWN 6.9%, on average.
3. The Consumption Devices Category has only 1 portfolio participant  (GNLN) focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers and it went UP 0.8% in price.
4. The Biotechnology Category has only 1 portfolio participant (AVCNF) which markets new drugs utilizing cannabinoids (CBD) and it went DOWN 3.0%.

*Please note: The 25 pure-play stocks in the munKNEE.com Pure-Play Pot Stock Portfolio are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products so as to reflect the true health of the marijuana industry in the U.S. and Canada.